Dr. Munir Ghesani explains how PLUVICTO® can now be used before chemotherapy for some PSMA-positive prostate cancer patients. Here’s what changed and who qualifies.
PLUVICTO
Understanding PSMA: What Patients Facing Prostate Cancer Should Know
PSMA is the molecular target behind today’s most precise prostate cancer therapies. Nuclear Oncologist Dr. Babak Saboury explains what it is, how it works, and what your PSMA PET results mean for your treatment.